Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - Contacts and Locations

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

This study is currently recruiting participants.

Study NCT00643097. Last updated on September 22, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00643097

Locations


United States, North Carolina
	Duke Comprehensive Cancer Center	Recruiting
	Durham, North Carolina, United States, 27710
	Contact: Clinical Trials Office - Duke Comprehensive Cancer Center 888-275-3853

United States, Texas
	M. D. Anderson Cancer Center at University of Texas	Recruiting
	Houston, Texas, United States, 77030-4009
	Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U 713-792-3245

Sponsors and Collaborators

Duke University

National Cancer Institute (NCI)

Investigators


Principal Investigator:	Duane Mitchell, MD, PhD	Duke University